These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 775542)

  • 21. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
    Rikans LE; Notley BA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):574-8. PubMed ID: 7062268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver and metabolism of drugs].
    Darnis F
    Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of aztreonam on immunohistochemical localizations of cytochrome P-450 (M-1) in male rats.
    Sagami F; Tsukidate K; Fukuda T; Hayashi S; Horie T
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):337-44. PubMed ID: 2813957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of vitamin D2 on the monooxygenase activity of the rat liver].
    Sushko LI; Abakumov GZ; Lukienko PI; Voronov GG
    Vopr Med Khim; 1985; 31(4):108-11. PubMed ID: 3876645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
    Miguet JP; Allemand H; Joanne C; Dhumeaux D
    Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
    [No Abstract]   [Full Text] [Related]  

  • 29. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions.
    Fouts JR
    Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 31. [Unexpected high plasma level of drugs. Blocked transporter can be the cause].
    Fromm MF
    MMW Fortschr Med; 2001 Dec; 143(51-52):36-7. PubMed ID: 11824163
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of fleroxacin on hepatic drug metabolism in the rat.
    Grech-Bélanger O; Francoeur J; Le Bel M
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
    Tsuru M; Erickson RR; Holtzman JL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):658-61. PubMed ID: 7108769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different changes on hepatic drug-metabolizing system caused by non-steroid anti-inflammatory drugs.
    Fracasso ME; Gasperini R; Leone R
    Acta Physiol Hung; 1990; 75 Suppl():109-10. PubMed ID: 2371835
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
    Bachmann KA; Yang C; Jahn D; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual differences in the disposition of drugs metabolised in the body.
    Alvan G
    Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
    [No Abstract]   [Full Text] [Related]  

  • 38. Molybdenum hydroxylases as drug-metabolizing enzymes.
    Beedham C
    Drug Metab Rev; 1985; 16(1-2):119-56. PubMed ID: 3905316
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxicological implications of drug metabolism.
    Welch RM
    Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
    [No Abstract]   [Full Text] [Related]  

  • 40. Lead and polychlorinated biphenyls: effects on heme and drug metabolism.
    Alvares AP; Kappas A
    Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.